Disclosures for "Analysis of Calcitonin Gene-Related Peptide Receptor Monoclonal Antibody and Antagonist Usage and Medication Switch Profile from a Tertiary Care Facility"
-
Dr. Wang has nothing to disclose.
-
Michael Li has received personal compensation for serving as an employee of Pascal Metrics. Michael Li has received stock or an ownership interest from Pascal Metrics.
-
Dr. Wrem has nothing to disclose.
-
Mary Hopkins has nothing to disclose.
-
Dr. Ren has received personal compensation for serving as an employee of Merck & Co., Inc.. Dr. Ren has stock in Merck & Co., Inc..
-
An immediate family member of Dr. Yuan has received personal compensation for serving as an employee of Merck. Dr. Yuan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Yuan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Salvia. Dr. Yuan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovous. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Regional Anesthesia and Pain Medicine. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Headache and Pain Reports. The institution of Dr. Yuan has received research support from NIH. Dr. Yuan has received publishing royalties from a publication relating to health care. Dr. Yuan has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH.